Variant report
Variant | nsv613269 |
---|---|
Chromosome Location | chr9:7742476-7759331 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561908635 | chr9:7749215-7749216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529218924 | chr9:7749216-7749217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547645957 | chr9:7749327-7749328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74462295 | chr9:7749337-7749338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191811150 | chr9:7749349-7749350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12337599 | chr9:7749357-7749358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184554661 | chr9:7749361-7749362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538059759 | chr9:7749372-7749373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368321333 | chr9:7749393-7749394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146061056 | chr9:7749405-7749406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544320415 | chr9:7749415-7749416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535801869 | chr9:7749422-7749423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574701802 | chr9:7749426-7749427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540470180 | chr9:7749438-7749439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372580530 | chr9:7749451-7749452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35323148 | chr9:7749486-7749487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs397717341 | chr9:7749494-7749495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs202052322 | chr9:7749495-7749496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111803805 | chr9:7749528-7749529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138798065 | chr9:7749531-7749532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192183419 | chr9:7749538-7749539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149381746 | chr9:7749566-7749567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10976548 | chr9:7749594-7749595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550031551 | chr9:7754005-7754006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184535744 | chr9:7754016-7754017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189025841 | chr9:7754028-7754029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548279316 | chr9:7754056-7754057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566585392 | chr9:7754061-7754062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10758897 | chr9:7754113-7754114 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs113379302 | chr9:7754121-7754122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552402565 | chr9:7754127-7754128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79158920 | chr9:7754142-7754143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369689732 | chr9:7754167-7754168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146730445 | chr9:7754169-7754170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567988316 | chr9:7754176-7754177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535384916 | chr9:7754184-7754185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140359785 | chr9:7754185-7754186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112181765 | chr9:7754201-7754202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145429801 | chr9:7754212-7754213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs146529428 | chr9:7754222-7754223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149100828 | chr9:7754237-7754238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558016919 | chr9:7754278-7754279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143657570 | chr9:7754313-7754314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543372098 | chr9:7754321-7754322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148079403 | chr9:7754330-7754331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530049657 | chr9:7754375-7754376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541859491 | chr9:7754394-7754395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560110937 | chr9:7754404-7754405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527809920 | chr9:7754422-7754423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7022742 | chr9:7754451-7754452 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Chordoma | 21215367 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:7749200-7749600 | Enhancers | Fetal Lung | lung |
2 | chr9:7754000-7755400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr9:7754200-7755400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr9:7754800-7755000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr9:7754800-7755000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr9:7754800-7755000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr9:7754800-7755200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr9:7754800-7755400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr9:7754800-7755400 | Enhancers | HSMMtube | muscle |
10 | chr9:7755000-7756400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr9:7755400-7756400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
12 | chr9:7755600-7756600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr9:7755600-7756800 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
14 | chr9:7755800-7757200 | Enhancers | GM12878-XiMat | blood |
15 | chr9:7756000-7756600 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
16 | chr9:7756000-7756800 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
17 | chr9:7756200-7757200 | Enhancers | HMEC | breast |
18 | chr9:7756400-7756600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr9:7756400-7756800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
20 | chr9:7756400-7757000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
21 | chr9:7756400-7757200 | Enhancers | NHEK | skin |
22 | chr9:7756400-7757400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
23 | chr9:7756600-7757200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
24 | chr9:7757200-7763000 | Weak transcription | GM12878-XiMat | blood |